Skip to main

FDA Engagements

ASGCT partners with the FDA to advance the development and regulation of cell and gene therapies through transparent scientific exchange.

Collaborating for Regulatory Progress

Explore ASGCT's key collaborative initiatives designed to address CMC, clinical, and regulatory challenges.

CGT Science Series

A collaboration between ASGCT, BIO, and CBER, the CGT Science Series facilitates technical exchange between sponsors and reviewers.

FDA Liaison Meeting

This annual meeting brings together Society experts and Agency leadership for a focused dialogue on key regulatory issues in cell and gene therapy.

Workshops

ASGCT is proud to partner with FDA to offer virtual workshops that tackle critical topics that impact both academic research and industry development.